Key result
Systemic-to-pulmonary collaterals track with PH severity and worsening but show no association with 5-year survival.
Why the study?
The clinical impact, prevalence, clinical correlates, and prognostic relevance of systemic-to-pulmonary arterial collaterals across pulmonary hypertension groups remained unclear.
Does the presence of high-grade systemic-to-pulmonary arterial collaterals (SPCs) predict 5-year mortality and clinical worsening in adult patients with pulmonary hypertension?
Cohort (n=434)
No
Does the presence of high-grade systemic-to-pulmonary arterial collaterals (SPCs) predict 5-year mortality and clinical worsening in adult patients with pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
Systemic-to-pulmonary arterial collaterals are commonly recruited across all precapillary pulmonary hypertension groups in correlation with hemodynamic severity (particularly PVR) and risk scores, but they do not independently affect 5-year survival.
BACKGROUND: The clinical impact of systemic-to-pulmonary arterial collaterals (SPCs) across pulmonary hypertension (PH) groups remains unclear. The authors evaluated the prevalence, clinical correlates, and prognostic relevance of SPCs in a comprehensive PH cohort. METHODS: The authors retrospectively analyzed 434 adult PH patients diagnosed per European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines. Baseline risk was evaluated using multiparametric risk scores. All patients underwent diagnostic heart catheterization and angiography, with SPC recruitment semi-quantitatively graded from 0 (none) to 3 (severe, high grade: 2-3). RESULTS: Mean age was 51.9 ± 18.2 years (61.1% female; groups 1, 2, 3, and 4 comprised 51.6%, 3.4%, 10.1%, and 33.2%, respectively). High-grade SPCs were significantly more prevalent in group 4 (58.3%) compared to groups 1 (30.4%), 2 (20.0%), and 3 (6.8%) (P <.001). Higher SPC grade significantly correlated with PH severity across clinical, echocardiographic, hemodynamic, and risk score measures (P <.001). Although higher SPC grades were linked to clinical worsening requiring parenteral prostacyclins (P = .027), they were not associated with overall 5-year survival, regardless of pulmonary vascular resistance severity or non-CTEPH etiology (P = .920). Only the Registry to Evaluate Early and Long-Term PAH Disease Management 2.0 score independently predicted mortality (hazard ratio [HR] = 1.19, P <.001, 95% CI: 1.13-1.26). CONCLUSION: Systemic-to-pulmonary arterial collaterals are recruited across all PH etiology groups beyond group 4. While SPC recruitment serves as a marker of advanced pulmonary vascular involvement and elevated risk status, it does not act as an independent driver of long-term mortality.
No takes yet. Share an insight, caveat, or question.
Kaymaz et al. (2026) conducted a cohort in Chronic and severe precapillary pulmonary hypertension (n=434). High-grade systemic-to-pulmonary arterial collaterals (SPC grade 2-3) vs. Low-grade or absent systemic-to-pulmonary arterial collaterals (SPC grade 0-1) was evaluated on 5-year overall survival / all-cause mortality (HR 0.87, 95% CI 0.64-1.17, p=0.359). High-grade systemic-to-pulmonary arterial collaterals correlated with pulmonary hypertension severity but did not independently predict mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: